About RECOVER-AUTONOMIC

Meet the Team

The RECOVER-AUTONOMIC clinical trials, Severe POTS (IVIG) and Moderate POTS (Ivabradine), are led by Christopher Granger, MD, and Cyndya Shibao, MD, MSCI, FAHA, FAAS. They work closely with other members of the RECOVER-AUTONOMIC team, including the principal investigators, or lead researchers, listed below, Long COVID patients and community members, doctors, and scientists, to implement and monitor the conduct of the studies. All team members are valuable contributors to this important research and share their knowledge and experience to help guide the studies.

This research is funded by the National Institutes of Health (NIH) Researching COVID to Enhance Recovery (RECOVER) Initiative. The Duke Clinical Research Institute (DCRI) is the Clinical Trials Data Coordinating Center.

Learn more about design of the clinical trials

RECOVER-AUTONOMIC Principal Investigators

Christopher Granger, MD Duke University Medical Center

Cyndya Shibao, MD, MSCI, FAHA, FAAS Vanderbilt University Medical Center

Peter Novak, MD, PhD Brigham and Women’s Hospital

Pam R. Taub, MD, FACC, FASPC University of California San Diego Health

Tae Chung, MD Johns Hopkins University School of Medicine

Huiman Xie Barnhart, PhD Duke Clinical Research Institute